Literature DB >> 29032867

Adherence to topical treatment of glaucoma, risk and protective factors: A review.

M C Vélez-Gómez1, E M Vásquez-Trespalacios2.   

Abstract

INTRODUCTION: Glaucoma is a chronic asymptomatic disease, progressing to loss of vision. Elevated intraocular pressure is the only modifiable factor. Adherence to glaucoma treatment varies from 2-80%.
OBJECTIVE: To evaluate factors associated with adherence to topical glaucoma treatment reported in the literature, and to identify protective factors and risk factors, as well as modifiable and non-modifiable factors, in order to take them into account to perform interventions in adherence.
MATERIALS AND METHODS: A bibliographic search of articles published in the last 8 years in databases such as Clinical Key, Cochrane (OVID), EBSCO, Lilacs, PubMed and Science Direct, of different observational studies that performed a measurement of the treatment of glaucoma and to identify associated factors.
RESULTS: A total of 7 studies were selected that directly and indirectly measured adherence to glaucoma treatment. Different risk and protective factors for adherence to treatment were found. These showed that African-American race, poor education, low personal income, and high treatment costs, are strongly related to poor adherence to treatment. It was also found that educational interventions and a good patient- physician relationship impacted positively on adherence.
CONCLUSION: The results found are a guide for risk and protective factors for adherence to treatment of glaucoma. It is cost effective to educate patients to positively impact adherence. By identifying such factors, attention can be focused on poor adherence patients.
Copyright © 2017 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Adherence; Adherencia; Adherencia al tratamiento del glaucoma; Compliance; Compromiso; Glaucoma; Glaucoma treatment adherence; Management; Manejo; Race and glaucoma treatment adherence; Raza y adherencia al tratamiento del glaucoma

Mesh:

Year:  2017        PMID: 29032867     DOI: 10.1016/j.oftal.2017.07.012

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol (Engl Ed)        ISSN: 2173-5794


  8 in total

1.  A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study.

Authors:  Julia Tau; María Silvia Passerini; Melina Del Papa; Alejandro Aguilar; Alejandro Berra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-11       Impact factor: 3.117

2.  Potentially inappropriate prescriptions of anticholinergic medications in patients with closed-angle glaucoma.

Authors:  Luis Fernando Valladales-Restrepo; Jorge Enrique Machado-Alba
Journal:  Int Ophthalmol       Date:  2019-12-03       Impact factor: 2.031

3.  Psychosocial Predictors of Glaucoma Medication Adherence Among the Support, Educate, Empower (SEE) Personalized Glaucoma Coaching Pilot Study Participants.

Authors:  Mariam Salman; Chris Andrews; Michele Heisler; Deborah Darnley-Fisch; Paula Anne Newman-Casey
Journal:  Am J Ophthalmol       Date:  2020-02-19       Impact factor: 5.258

4.  Letter to the Editor: The Impact of COVID-19 on the Ophthalmic Pharmaceutical Supply.

Authors:  Arjun Watane; Nicolas A Yannuzzi; Jayanth Sridhar
Journal:  Optom Vis Sci       Date:  2021-05-01       Impact factor: 2.106

5.  Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya - A Pilot Study.

Authors:  Ian Murdoch; David Nyakundi; Helen Baker; Simon Dulku; Daniel Kiage
Journal:  Patient Prefer Adherence       Date:  2020-02-10       Impact factor: 2.711

6.  Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost.

Authors:  Carl Erb; Ingeborg Stalmans; Milko Iliev; Francisco José Muñoz-Negrete
Journal:  Clin Ophthalmol       Date:  2021-03-02

7.  Eye Examination Recency among African American Older Adults with Chronic Medical Conditions.

Authors:  Mohsen Bazargan; Tavonia Ekwegh; Sharon Cobb; Edward Adinkrah; Shervin Assari
Journal:  Healthcare (Basel)       Date:  2020-04-12

Review 8.  Comprehensive eye care - Issues, challenges, and way forward.

Authors:  Maria Vittoria Cicinelli; Srinivas Marmamula; Rohit C Khanna
Journal:  Indian J Ophthalmol       Date:  2020-02       Impact factor: 2.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.